Sector: health
Conviction from: NASDAQ
52-week range: 21.9160.91
Veracyte is a diagnostics company offering genomic tests and software that help physicians assess cancer risk and guide treatment across thyroid, lung, prostate, and other indications.
2 tracked filer(s) hold this · 0 opened, 1 added, 1 trimmed in 30-SEP-2026
Aggregate 13FScore 54 — mean of 2 scored holder(s) · buyers (new/add) avg 52. Higher = the smart money in this name has the better track record.
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
1 disclosed trade(s) by 1 filer(s).